Publications
Export 43 results:
Author Title Type [ Year
Filters: Author is John CS Breitner [Clear All Filters]
Association of PPP2R1A with Alzheimer's disease and specific cognitive domains.. Neurobiol Aging. 81:234-243.
.
2019. Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.. Alzheimers Dement. 15(7):951-960.
.
2019. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.. Nat Commun. 10(1):2240.
.
2019. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia.. Gigascience. 8(5)
.
2019. Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology.. Alzheimers Dement. 15(9):1160-1171.
.
2019. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.. Neurology. 92(18):e2070-e2080.
.
2019. MR-based age-related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan.. Hum Brain Mapp.
.
2019. No apparent effect of naproxen on CSF markers of innate immune activation.. Ann Clin Transl Neurol. 6(6):1127-1133.
.
2019. Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease.. Neurobiol Aging. 66:180.e1-180.e9.
.
2018. Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.. J Alzheimers Dis. 63(2):577-590.
.
2018. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.. Brain. 141(6):1871-1883.
.
2018. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.. J Alzheimers Dis. 61(4):1493-1507.
.
2018. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.. JAMA Neurol.
.
2018. Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.. Hum Brain Mapp. 39(2):971-984.
.
2018. Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease.. Biol Psychiatry Cogn Neurosci Neuroimaging. 3(5):463-472.
.
2018. Comment: MCI trials-Categorical "square pegs" in dimensional "round holes"? Neurology. 88(18):1757.
.
2017. Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.. J Alzheimers Dis. 60(4):1589-1600.
.
2017. Dementia registries around the globe and their applications: A systematic review.. Alzheimers Dement.
.
2017. Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on Glia.. ACS Chem Neurosci.
.
2017. Odor identification as a biomarker of preclinical AD in older adults at risk.. Neurology. 89(4):327-335.
.
2017. .
2017. .
2017. 'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials.. J Prev Alzheimers Dis. 3(4):229-235.
.
2016. .
2016. .
2016.